Skip to content

Welcome to Discover Pharma! Today is : November 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Atomic ‘Hook’ in motor protein unlocks neuron cargo delivery secrets

    A team from the University of Tokyo and Juntendo University [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Manufacturing & Supply Chain

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    NurExone joins ARMI BioFab Startup Lab to boost US regenerative manufacturing

    NurExone Biologic Inc has been accepted into the BioFab Startup [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing

    Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Paris-based Tulyp Medical seeks FDA clearance following initial clinical use of perfusion device

    Tulyp Medical, a Paris-based medtech startup, has emerged from stealth [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics

    AmacaThera signs exclusive global licensing agreement with Pacira Biosciences for up to $230 million

    AmacaThera has entered an exclusive worldwide licensing agreement with Pacira [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    Minovia Therapeutics gains FDA orphan drug designation for MNV-201 in myelodysplastic syndrome

    Minovia Therapeutics has received orphan drug designation from the US [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    FDA grants Fast Track designation to Enterome’s EO2463 immunotherapy in follicular lymphoma

    Doron Therapeutics has dosed the first patients in its Phase [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Enterome’s EO2463 receives FDA fast track designation for follicular lymphoma watch-and-wait treatment

    Enterome has received Fast Track designation from the US Food [...]

    May 5, 2026
Previous141516Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys EGM detects genomic abnormalities in five-sample leukemia study
    Categories: Genomics and sequencing, Research & Development, Therapeutic Areas
  • Calibre secures CQC registration for nationwide AI health service
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Research & Development
  • Cyllene gene therapy for bladder disorder gains FDA RMAT designation
    Categories: Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top